05.13.2022

Antibiotice Iasi (ATB.RO), the biggest Romanian-held drug maker, reported a net profit net of RON8.6 million for the first three months of 2022, up 113.7% from the year-earlier period, in line with more

04.20.2022

Austrian construction company Strabag has won a contract worth RON327.9 million (over EUR66 million), excluding VAT, to build the new passenger terminal at Iasi airport, an EU-funded project. more

04.13.2022

Airline Blue Air on Wednesday said it would launch 11 new routes in the summer of 2022 and it would also open a new base in Iasi (north-eastern Romania). more

02.11.2022

Demand for office space in regional centers remains high, with corporate employees in secondary and tertiary cities returning to the office faster than those in Bucharest. more

02.10.2022

Nord Wind Power is the project company that broke the ice this year, obtaining the first technical permit to connect to the grid in 2022 for a wind farm in Iasi that, if completed, is estimated to be more

02.08.2022

Caretta, a manufacturer of metal tile roofing, metal fencing systems and industrial hall elements, wants to open new showrooms in 2022, despite fears of further increases in raw material prices. more

01.31.2022

Antibiotice Iasi (ATB.RO), the biggest local Romanian-held drug producer, projects total revenues worth RON448 million in 2022, up 15% on the year and net profit of RON32 million, 6% higher than in more

12.10.2021

Continental Romania, the largest automotive component manufacturer in the country, is investing EUR8 million in a new building in Iasi, which includes the engineering center, test laboratories and an more

12.10.2021

Antibiotice Iasi, the biggest local Romanian-held drug maker, aims for exports to weigh 50%-60% in turnover by 2028. more

08.11.2021

Pharmaceutical company Ropharma (RPH.RO) held by several Cyprus-based companies has secured approval from shareholders to sell an 8,852 square meter plot on Soseaua Bucium in Iasi to Rewe more

07.26.2021

Antibiotice Iasi (ATB.RO), the largest Romanian-held pharmaceutical producer, reported sales of RON161.4 million in the first half of 2021, up 10.2% from the same period in 2020, per calculations by more

07.07.2021

Pharmacy chain Ropharma (RPH.RO), owned by Mihai Miron, summoned shareholders for August 10 to approve the sale of a land plot in Iasi for RON2.02 million plus VAT. more

05.12.2021

Antibiotice Iasi (ATB.RO), the largest Romanian-held pharmaceutical producer, on Wednesday reported sales of RON66.1 million for the first quarter of 2021, down 10.2% on the year, and a net profit of more

04.21.2021

Shareholders of state-run Antibiotice Iasi (ATB.RO), the largest pharmaceutical producer in Romania, on Wednesday approved the distribution of dividends worth RON2.2 million from the 2020 profit, more

04.20.2021

The European Investment Bank (EIB) will grant a EUR250 million 27-year financing to Romania for a regional 850-bed hospital in Iasi, northeastern Romania. more

04.14.2021

Romanian state-owned Antibiotice Iasi (ATB.RO), the largest pharmaceutical producer in Romania, said in a stock market report on Wednesday that regional investment fund SIF Oltenia (SIF5.RO) reached more

04.12.2021

Scandinavian fashion retailer Marc O’Polo has opened its first store in northeast Romania, within the Palas Iasi shopping center; the retailer already is present within Iulius Mall Cluj. more

03.24.2021

Romanian state-owned Antibiotice Iasi (ATB.RO), the largest pharmaceutical producer in Romania, has invested RON14 million in new product research and equipment in 2020, double compared with 2019, per more

03.18.2021

Romanian state-owned Antibiotice Iasi (ATB.RO), the largest pharmaceutical producer in Romania, plans to distribute RON2.2 million as dividends from its 2020 profit of RON26 million profit. more

03.16.2021

Investment fund Oresa has completed the acquisition of the Solo Iasi industrial and logistics park from tester group, owned by Bogdan Pitigoi, marking the fund's entry on the local real estate market. more

03.11.2021

Giant Amazon will have a majority presence in Palas Campus, a project worth EUR120 million of Iulius Group, which is to become one of Amazon’s most powerful centers in Europe. more

02.25.2021

Antibiotice Iasi (ATB.RO), the largest pharmaceutical producer in Romania, on Thursday reported a 16% drop in net profit in 2002, to RON25 million. more

09.04.2020

Vel Pitar, the leader of the local milling and bakery market, is investing more than 50 million lei in upgrading its plant in Iasi and expanding the product range, the company officials say. more

07.09.2020

Antibiotice Iasi (ATB.RO), the largest pharmaceutical producer in Romania, has entered the US and UK markets with new medicines for Covid-19 by attending and winning tenders in the US and UK. more

05.20.2020

more